Peters R, Poulter R, Warner J, Beckett N, Burch L, Bulpitt C
Clinicians should review the full blood count and consider alternative glucose tests
Through its effects on cytoskeletal organization and blood flow, TB-500 is studied for its potential role in supporting recovery processes related to tendon injuries, ligaments, and other connective tissues under controlled research conditions
Is a Certificate of Analysis (CoA) available for my batch
Bottom Line The peptide craze is unfounded
Legitimate Research Directions: Some peptides DO have potential and are being properly studied: Thymosin Alpha-1: Immune support (approved in 35+ countries, trials in US) BPC-157: IF proper human trials ever happen LL-37: Antimicrobial applications Others: Many peptides have theoretical promise But ONLY if studied properly: Randomized controlled trials Safety studies FDA approval process Medical supervision The Problem: Most "wellness peptides" will NEVER go through this process because: They can't be patented (no profit incentive) Companies would rather sell in gray market Proper trials cost $100M+ If trials show they DON'T work, the market disappears So we're stuck in limbo: promising animal data, zero human data, aggressive marketing
